ATE225806T1 - D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet - Google Patents

D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet

Info

Publication number
ATE225806T1
ATE225806T1 AT95932735T AT95932735T ATE225806T1 AT E225806 T1 ATE225806 T1 AT E225806T1 AT 95932735 T AT95932735 T AT 95932735T AT 95932735 T AT95932735 T AT 95932735T AT E225806 T1 ATE225806 T1 AT E225806T1
Authority
AT
Austria
Prior art keywords
growth hormone
alkyltryptophane
hormone releasing
containing polypeptides
releasing activity
Prior art date
Application number
AT95932735T
Other languages
English (en)
Inventor
Bioscience Limited Ardana
Original Assignee
Bioscience Limited Ardana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI941954A external-priority patent/IT1270021B/it
Priority claimed from IT95MI001293A external-priority patent/IT1276734B1/it
Application filed by Bioscience Limited Ardana filed Critical Bioscience Limited Ardana
Application granted granted Critical
Publication of ATE225806T1 publication Critical patent/ATE225806T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
AT95932735T 1994-09-27 1995-09-13 D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet ATE225806T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI941954A IT1270021B (it) 1994-09-27 1994-09-27 "composti polipeptidici contenenti d-2-metiltriptofano aventi attivita'sull'aumento del camp intracellulare"
IT95MI001293A IT1276734B1 (it) 1995-06-16 1995-06-16 Composti polipeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della
PCT/EP1995/003601 WO1996010040A1 (en) 1994-09-27 1995-09-13 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone

Publications (1)

Publication Number Publication Date
ATE225806T1 true ATE225806T1 (de) 2002-10-15

Family

ID=26331189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932735T ATE225806T1 (de) 1994-09-27 1995-09-13 D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet

Country Status (21)

Country Link
US (1) US5795957A (de)
EP (1) EP0783521B8 (de)
JP (1) JP3810083B2 (de)
KR (1) KR100369105B1 (de)
CN (1) CN1121413C (de)
AT (1) ATE225806T1 (de)
AU (1) AU700066B2 (de)
CA (1) CA2201122A1 (de)
CZ (1) CZ291798B6 (de)
DE (1) DE69528531T2 (de)
DK (1) DK0783521T3 (de)
ES (1) ES2186730T3 (de)
HK (1) HK1001207A1 (de)
HU (1) HU221481B (de)
IL (1) IL115381A (de)
MX (1) MX9702275A (de)
PL (1) PL181588B1 (de)
PT (1) PT783521E (de)
RU (1) RU2157378C2 (de)
SK (1) SK284550B6 (de)
WO (1) WO1996010040A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
US20020111461A1 (en) 1999-05-21 2002-08-15 Todd C. Somers Low molecular weight peptidomimetic growth hormone secretagogues
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
WO1999039730A1 (fr) * 1998-02-09 1999-08-12 Kaken Pharmaceutical Co., Ltd. Preparation a administration orale contenant des peptides favorisant la secretion d'hormone de croissance
US5932548A (en) * 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease
US6696063B1 (en) * 1998-12-30 2004-02-24 Applied Research Systems Ars Holding N.V. Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
GB0603295D0 (en) 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1080470A (en) * 1963-12-31 1967-08-23 Merck & Co Inc Indole derivatives
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228156A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228155A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223019A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4226857A (en) * 1979-03-30 1980-10-07 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4224316A (en) * 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228158A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228157A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223021A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410513A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
BR8208035A (pt) * 1981-12-28 1983-11-22 Beckman Instruments Inc Peptideos sinteticos tendo atividade liberadora de hormonio do crescimento da pituitaria
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
DE68922602T2 (de) * 1988-01-28 1995-12-07 Polygen Holding Corp Polypeptide mit hormonwachstumsbefreiender wirkung.
DE3915361A1 (de) * 1989-05-11 1990-11-15 Merck Patent Gmbh Cyclopeptide
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
JPH08502250A (ja) * 1992-09-25 1996-03-12 スミスクライン・ビーチャム・コーポレイション 成長ホルモン放出ペプチド

Also Published As

Publication number Publication date
SK284550B6 (sk) 2005-06-02
HUT77525A (hu) 1998-05-28
KR100369105B1 (ko) 2003-04-07
DK0783521T3 (da) 2003-01-27
RU2157378C2 (ru) 2000-10-10
EP0783521B1 (de) 2002-10-09
SK39997A3 (en) 1997-09-10
IL115381A0 (en) 1995-12-31
JPH10506114A (ja) 1998-06-16
CZ291798B6 (cs) 2003-05-14
DE69528531T2 (de) 2003-06-05
JP3810083B2 (ja) 2006-08-16
AU3566895A (en) 1996-04-19
MX9702275A (es) 1997-06-28
ES2186730T3 (es) 2003-05-16
EP0783521B8 (de) 2003-04-09
CZ91497A3 (en) 1997-09-17
KR970706305A (ko) 1997-11-03
US5795957A (en) 1998-08-18
PL181588B1 (pl) 2001-08-31
HU221481B (en) 2002-10-28
EP0783521A1 (de) 1997-07-16
AU700066B2 (en) 1998-12-17
CA2201122A1 (en) 1996-04-04
PT783521E (pt) 2003-02-28
CN1121413C (zh) 2003-09-17
CN1158622A (zh) 1997-09-03
PL319382A1 (en) 1997-08-04
IL115381A (en) 2000-07-16
HK1001207A1 (en) 1998-06-05
WO1996010040A1 (en) 1996-04-04
DE69528531D1 (de) 2002-11-14

Similar Documents

Publication Publication Date Title
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
TR199501669A1 (tr) Peptid ve proteinlerin aerosol formülasyonlari.
DE69837264D1 (de) Dipeptidderivate zur förderung der sekretion von wachstumshormon
ATE197307T1 (de) Neuroaktive peptide
DE69732871D1 (de) Basisches Protein Zusammensetzung, basisches Peptid Zusammensetzung und deren Verwendung
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
EP0644769A4 (de) Biologisch aktive peptide mit n-terminalen substitutionen.
EP0875567A3 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DK148085C (da) Dipeptidet pyrglu-his(2,4-dinitrophenyl)-oh og fremgangsmaade til fremstilling af lh-rh og lh-rh-analoge peptider under anvendelse af dette dipeptid
ES2087337T3 (es) Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos.
MX169334B (es) Preparacion de liberacion sostenida
DE69002881D1 (de) Peptide und deren Benutzung.
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
GB9604518D0 (en) Novel compounds
DE69030316D1 (de) Schrittweiser c-terminaler abbau von peptiden und proteinen
DE68914057D1 (de) Peptide.
DE60044468D1 (de) Herstellung von sekretierten polypeptiden
NO893572L (no) Lunge-overflateaktivt protein og beslektet polypeptid.
ATE81531T1 (de) Biologisch aktive peptide tan-866.
IT8847737A0 (it) Procedimento per ottenere amminoacidi da sostanze proteiche per uso fertilizzante

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0783521

Country of ref document: EP

REN Ceased due to non-payment of the annual fee